Harmony Biosciences (HRMY.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec8

Harmony Biosciences Announces EPX-100 Phase III Clinical Trial Data for Dravet Syndrome

13:05

Nov24

Needham analyst reiterates buy rating on Harmony Biosciences

14:35

Harmony Biosciences Announces Positive Results for Gastro-Resistant Pitolisant Formulation Study

13:14

Nov14

Mizuho Securities Analyst Reiterates Buy Rating on Harmony Biosciences Holdings

05:48

Nov4

Harmony Biosciences released FY2025 9 Months Earnings on November 4 Pre-Market EST, actual revenue USD 624.68 M, actual EPS USD 2.3299

14:30

Harmony Biosciences released FY2025 Q3 earnings on November 4 Pre-Market (EST), actual revenue USD 239.46 M (forecast USD 222.68 M), actual EPS USD 0.87 (forecast USD 0.6619)

14:30

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 239.46 M, Net Income 50.87 M, EPS 0.87

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 200.49 M, Net Income 39.78 M, EPS 0.6799

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 184.73 M, Net Income 45.56 M, EPS 0.7799

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change